Fibrocell Science (FCSC) Stock Price, Quote, News and Overview
NASDAQ:FCSC - Nasdaq -
FCSC Quote, Performance and Key Statistics
NASDAQ:FCSC (12/12/2019, 8:00:00 PM)
3
0 (0%)
The current stock price of FCSC is 3 null. In the past month the price increased by 0.67%. In the past year, price increased by 50%.
About FCSC
Company Profile
Fibrocell Science, Inc. is an autologous cell and gene therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs. Fibrocell's most advanced drug candidate, azficel-T, uses its FDA-approved proprietary autologous fibroblast technology and is in a Phase II clinical trial for the treatment of chronic dysphonia resulting from vocal cord scarring or atrophy. In collaboration with Intrexon Corporation, a leader in synthetic biology, Fibrocell is also developing gene therapies for orphan skin diseases using gene-modified autologous fibroblasts. The Company's lead orphan gene-therapy drug candidate, FCX-007, is in late stage pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Fibrocell is also in pre-clinical development of FCX-013, its second gene-therapy drug candidate, for the treatment of linear scleroderma.
Company Info
Fibrocell Science
405 EAGLEVIEW BOULEVARD
EXTON PA 19341
CEO: John M. Maslowski
Phone: 484-713-6000
Fibrocell Science / FCSC FAQ
What is the stock price of Fibrocell Science today?
The current stock price of FCSC is 3 null.
What is the ticker symbol for Fibrocell Science stock?
The exchange symbol of Fibrocell Science is FCSC and it is listed on the Nasdaq exchange.
On which exchange is FCSC stock listed?
FCSC stock is listed on the Nasdaq exchange.
What is Fibrocell Science worth?
Fibrocell Science (FCSC) has a market capitalization of 29.27M null. This makes FCSC a Nano Cap stock.
What are the support and resistance levels for Fibrocell Science (FCSC) stock?
Fibrocell Science (FCSC) has a support level at 3 and a resistance level at 3.01. Check the full technical report for a detailed analysis of FCSC support and resistance levels.
Should I buy Fibrocell Science (FCSC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FCSC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FCSC, evaluating the profitability, health, valuation and growth aspects
- Fibrocell Science (FCSC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Fibrocell Science (FCSC) Sales and EPS estimates to see what analysts future expectations are.
- Fibrocell Science (FCSC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Fibrocell Science (FCSC) Insider and Institutional Ownership to learn about the owners and their transactions.
- Fibrocell Science (FCSC) Stock Chart to make your own analysis
- Fibrocell Science (FCSC) Latest news and press-releases to stay up to date.
Does Fibrocell Science (FCSC) stock pay dividends?
FCSC does not pay a dividend.
What is the Price/Earnings (PE) ratio of Fibrocell Science (FCSC)?
The PE ratio for Fibrocell Science (FCSC) is 16.67. This is based on the reported non-GAAP earnings per share of 0.18 and the current share price of 3 null. Check the full fundamental report for a full analysis of the valuation metrics for FCSC.
FCSC Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to FCSC. When comparing the yearly performance of all stocks, FCSC is one of the better performing stocks in the market, outperforming 82.79% of all stocks.
FCSC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to FCSC. There are concerns on the financial health of FCSC while its profitability can be described as average.
FCSC Financial Highlights
Over the last trailing twelve months FCSC reported a non-GAAP Earnings per Share(EPS) of 0.18000000000000005. The EPS increased by 103.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -3.29% | ||
| ROA | -2.7% | ||
| ROE | N/A | ||
| Debt/Equity | 0.47 |
FCSC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 60% to FCSC. The Buy consensus is the average rating of analysts ratings from 1 analysts.